Jānis Gardovskis

Safety and Efficacy of Tigecycline in Treatment of Skin and Skin Structure Infections: Results of a Double-Blind Phase 3 Comparison Study with Vancomycin-Aztreonam

Johannes Breedt, Jüri Teras, Jānis Gardovskis et al. · Antimicrobial Agents and Chemotherapy · 2005 · 190 citations · Full text

Double-blind Phase 3, Health Sciences, Antimicrobial Stewardship +13

IGNITE4: Results of a Phase 3, Randomized, Multicenter, Prospective Trial of Eravacycline vs Meropenem in the Treatment of Complicated Intraabdominal Infections

Joseph S. Solomkin, Jānis Gardovskis, Kenneth Lawrence et al. · Clinical Infectious Diseases · 2018 · 187 citations · Full text

Omadacycline for Acute Bacterial Skin and Skin-Structure Infections

William O’Riordan, Sinikka Green, J. Scott Overcash et al. · New England Journal of Medicine · 2019 · 148 citations

Efficacy and safety of delafloxacin compared with vancomycin plus aztreonam for acute bacterial skin and skin structure infections: a Phase 3, double-blind, randomized study

John Pullman, Jānis Gardovskis, Brett Farley et al. · Journal of Antimicrobial Chemotherapy · 2017 · 100 citations · Full text

Evaluation of the pharmacodynamics and pharmacokinetics of the PARP inhibitor olaparib: a Phase I multicentre trial in patients scheduled for elective breast cancer surgery

Nigel Bundred, Jānis Gardovskis, Janusz Jaśkiewicz et al. · Investigational New Drugs · 2013 · 88 citations

Parp Inhibitor Olaparib, Surgical Oncology, Breast Oncology +9